*Image is for illustration only. Medication is compounded and dispensed by a licensed third-party pharmacy. -
Tirzepatide (concentration varies)
Appropriate dose will be determined by a licensed provider during your complimentary online exam.
-
GIP/GLP-1 (tirzepatide), is a dual-action therapy that mimics two hormones:
GLP-1 helps with fullness and blood sugar
GIP (glucose-dependent insulinotropic polypeptide) further supports insulin response and may enhance fat metabolism and appetite control
Because it targets two pathways instead of one, GIP/GLP-1 meds often lead to greater weight loss for many people, Stronger blood sugar improvements, and similar or sometimes better appetite suppression.
Enhances glucose-dependent insulin secretion
Suppresses glucagon secretion
Slows gastric emptying
Influences brain regions involved in appetite regulation, leading to reduced hunger and caloric intake
Improves insulin sensitivity
Helps to decrease internal inflammation
-
Important: This information is not medical advise. Other side effects may occur. Consult your healthcare provider for personalized medical advice.
Potential Common Side Effects:
Nausea, stomach pain, vomiting
Acid Reflux
Constipation, diarrhea
Injection site reactions are common (injection form)
Less Common Reactions:
Hypoglycemia
Gastroparesis
Kidney issues
Allergic reactions
Reports of suicidal thoughts and behaviors
Not Recommended If:
You have a known allergy to any ingredients.
NOT suitable for individuals with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Syndromes (MEN 2)
NOT suitable for individuals with type 1 diabetes or diabetic ketoacidosis
Should not be used alongside other GLP-1 receptor medications
Gastric emptying may be delayed, requiring caution for procedures involving sedation or general anesthesia due to aspiration risk
Use caution in those with a history of diabetic retinopathy
Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk
Avoid use during pregnancy and breastfeeding. Discontinue two months prior to becoming pregnant.
This is not a complete list of all possible side effects. If you experience unusual or severe symptoms, stop use and contact your healthcare provider.
-
Q: How long does it take to see results?
A: Benefits like appetite reduction and weight loss may be observed within weeks, but individual responses vary.
Q: Can I use this with other medications?
A: It can be used with other medications, but it should not be used with other GLP-1 medications. Always inform your healthcare provider about all medications you're taking to to address possible interactions.
Q: What if I miss a dose?
A: Contact your healthcare provider for guidance on missed doses.
Q: How does a GLP-1 (Semaglutide) differ from a GIP/GLP-1 (Tirzepatide)?
A: GLP-1 (semaglutide) mimics one hormone called GLP-1 (glucagon-like peptide-1). It helps:
Reduce appetite and cravings
Slow digestion so you feel full longer
Improve blood sugar control
GIP/GLP-1 (tirzepatide), is a dual-action therapy that mimics two hormones:
GLP-1 helps with fullness and blood sugar
GIP (glucose-dependent insulinotropic polypeptide) further supports insulin response and may enhance fat metabolism and appetite control
Because it targets two pathways instead of one, GIP/GLP-1 meds often lead to greater weight loss for many people, Stronger blood sugar improvements, and similar or sometimes better appetite suppression.